1.
Kaposi’s sarcoma–associated herpesvirus (KSHV) uses immune‑evasion strategies to support successful infection, including the activity of its viral E3 ubiquitin ligase, K5 [...]
2010 | Thesis |
2.
Live-attenuated viruses are key to vaccine strategies, yet mechanisms driving immune responses to replication-deficient strains remain unclear. Using a murine cytomegalov [...]
2013 | Dissertation |
3.
4.
5.
CD8⁺ T cells play a central role in antiviral immunity by eliminating infected cells and establishing immune memory. While acute viral infections are typically cleared, h [...]
2007 | Dissertation |
6.
Kaposi sarcoma (KS) is an angioproliferative tumor with infectious etiology, driven by viral infection of endothelial cells (EC) by Kaposi sarcoma herpesvirus (KS [...]
2016-06-01 | Dissertation |
7.
This dissertation identifies novel roles for the insulin-like growth factor (IGF) system and cathepsin B in Kaposi sarcoma–associated herpesvirus (KSHV)-mediated tumorige [...]
2007 | Dissertation |
8.
Vaccination of rhesus macaques with rhesus cytomegalovirus strain 68-1 expressing SIV proteins (RhCMV/SIV) results in stringent control of SIV replication. Approximately [...]
2016-06-01 | Dissertation |
9.
Kaposi sarcoma herpesvirus (KSHV) is the infectious etiological agent of several malignancies, lymphoproliferative disorders, and immune-dysfunction syndromes with signif [...]
2018-06-01 | Dissertation |
10.
Two closely related gammaherpesviruses, Kaposi’s sarcoma-associated herpesvirus (KSHV) and rhesus macaque rhadinovirus (RRV), are unique in that they express [...]
2014 | Dissertation |